Circulating microRNAs: Emerging Biomarkers of Liver Disease
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Development of reliable, noninvasive biomarkers that allow for diagnosis, risk stratification, and monitoring of disease changes over time or in response to specific therapies represents a key priority in the field of hepatology. Recent evidence has uncovered the role of microRNAs as potential ideal biomarkers of liver injury in various acute and chronic liver diseases. These small noncoding RNAs are released to the extracellular space in a stress-specific manner and are remarkably stable in most bodily fluids including blood, where they circulate in specific compartments including extracellular vesicles and protein complexes. In this review, the authors provide a concise overview of available information on the emerging role of quantitation of circulating microRNAs in different liver diseases and their use as biomarkers for both diagnosis and prognosis assessment. Additionally, several key issues that still need to be addressed for microRNAs to become useful tools in daily clinical practice are critically reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564
Ninomiya, M., Kondo, Y., Funayama, R., Nagashima, T., Kogure, T., Kakazu, E., Kimura, O., Ueno, Y., Nakayama, K., & Shimosegawa, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066086 · Cited by 83
Cited by
Vienberg, S., Geiger, J., Madsen, S., & Dalgaard, L. T. (2017) · Acta Physiologica · doi:10.1111/apha.12681 · Cited by 373
Momen-Heravi, F., Saha, B., Kodys, K., Catalano, D., Satishchandran, A., & Szabo, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0623-9 · Cited by 307
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Arguello, G., Balboa, E., Arrese, M., & Zanlungo, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.015 · Cited by 306
Self-citationNeutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Calvente, C. J., Tameda, M., Johnson, C. D., del Pilar, H., Lin, Y. C., Adronikou, N., De Mollerat Du Jeu, X., Llorente, C., Boyer, J., & Feldstein, A. E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122258 · Cited by 268
“Because microvesicles are increasingly recognized as endogenous carriers of microRNAs (39) and macrophages and neutrophils are within close vicinity in the hepatic sinusoids (40–43), we assessed the presence of CD177 in hepatic macrophages of WT, miR-223–/–, and anti-Ly6G mAb–treated mice during SRLI by staining with…”
BackgroundMethodSelf-citationMicroRNAs in brown and beige fat
Goody, D., & Pfeifer, A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.05.003 · Cited by 54
Metadata
- Authors
- Arrese, M., Eguchi, A., & Feldstein, A.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2015-01-29
- Volume
- 35
- Issue
- 01
- Pages
- 043-054
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2002387613
- Cited by
- 82
- References
- 5
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating microRNAs: Emerging Biomarkers of Liver Disease. https://app.cochat.ai/papers/10.1055/s-0034-1397348
- The paper
- Arrese, M., Eguchi, A., & Feldstein, A. (2015). Circulating microRNAs: Emerging Biomarkers of Liver Disease. Seminars in Liver Disease. https://doi.org/10.1055/s-0034-1397348
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.